Home

P20

Latest update from King’s College London

Pictured above, Dr Paramala Santosh, leading the clinical research team at King's College London and research assistant, Federico Fiori, with Rachael Bloom, Executive Director & John Sharpe, Chairman of Reverse Rett

Last year, Reverse Rett provided...

Research made easy: Ketamine Clinical Trial

by Rachael Bloom

Ketamine? Isn’t that a tranquiliser?

Ketamine is a sedative which is most often used as an anaesthetic in operations. However, at much lower doses it has been shown to significantly improve symptoms in disorders such as major...

Research made easy: Shushing the Long Genes

by Rachael Bloom

Rett Syndrome may result from over-expression of long genes

Let’s start at the beginning:

Cells are the basic building blocks of life.

Inside the cell is a compartment called a nucleus.

Inside the nucleus are chromosomes.

...

More news about Trofinetide

By Rachael Bloom

Neuren have announced today (March 2nd 2015)  that their FDA application for Breakthrough Therapy status for Trofinetide to treat the symptoms of Rett Syndrome has been denied.

The announcement states: 'Breakthrough Therapy will...

Page 3 of 4 pages